A committee in the US Senate will investigate the pricing of the Novo Nordisk drugs Ozempic and Wegovy, Ritzau reports. At the head of the investigation of the diabetes and weight loss drug is the independent senator Bernie Sanders, who has previously sought to become the presidential candidate for the Democrats. Sanders has written a […]
Full version of this article is only available to subscribers.
Already a subscriber, sign in here:
Gain unlimited access to all of The Copenhagen Post
Our independent reporting can only be published with support from our readers.
Monthly subscription
119
DKK/month.
(Billed once a month)
Give us a try
6 month subscription
99
DKK/month.
(Billed twice a year)
Save 120 DKK
Yearly subscription
79
DKK/month.
(Billed once a year)
Save 480 DKK
